Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2490
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report ; volume:18 ; number:1 ; day:18 ; month:4 ; year:2018 ; pages:1-4 ; date:12.2018
BMC urology ; 18, Heft 1 (18.4.2018), 1-4, 12.2018

Creator
Noguchi, Go
Contributor
Tsutsumi, Sohgo
Yasui, Masato
Ohtake, Shinji
Umemoto, Susumu
Nakaigawa, Noboru
Yao, Masahiro
Kishida, Takeshi
SpringerLink (Online service)

DOI
10.1186/s12894-018-0339-2
URN
urn:nbn:de:101:1-2018062522433966936414
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Noguchi, Go
  • Tsutsumi, Sohgo
  • Yasui, Masato
  • Ohtake, Shinji
  • Umemoto, Susumu
  • Nakaigawa, Noboru
  • Yao, Masahiro
  • Kishida, Takeshi
  • SpringerLink (Online service)

Other Objects (12)

Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma

Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report

Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma

Metastatic Merkel cell carcinoma response to nivolumab

Metastatic Merkel cell carcinoma response to nivolumab

Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab

Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab

Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma

Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma

Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab

Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab

The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab

The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab

Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma

Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis

Related objects